21-OHD

Clinical trials for 21-OHD explained in plain language.

Never miss a new study

Get alerted when new 21-OHD trials appear

Sign up with your email to follow new studies for 21-OHD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Terminated 1

New hope for kids with rare hormone disorder: drug may cut steroid doses

Disease control Terminated

This study tested an experimental drug called tildacerfont in 67 children aged 2 to 17 with congenital adrenal hyperplasia (CAH), a genetic condition that disrupts hormone production. The goal was to see if adding this once-daily pill to standard steroid treatment could improve d…

Matched conditions: 21-OHD

Phase: PHASE2 • Sponsor: Spruce Biosciences • Aim: Disease control

Last updated Jun 27, 2026 08:06 UTC

21-OHD

Get alerted when new 21-OHD trials appear

New hope for kids with rare hormone disorder: drug may cut steroid doses